Assessment of neurovascular uncoupling: APOE status is a key driver of early metabolic and vascular dysfunction
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.13842 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Kristen D Onos und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Jackson Laboratory, Bar Harbor, Maine, USA. Hauptthemen laut MEDLINE: Apolipoprotein E4, Apolipoproteins E, Neurovascular Coupling, Positron-Emission Tomography. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NIH/NIA.
Abstract (Originalsprache)
BACKGROUND Alzheimer's disease (AD) is the most common cause of dementia worldwide, with apolipoprotein Eε4 (APOEε4) being the strongest genetic risk factor. Current clinical diagnostic imaging focuses on amyloid and tau; however, new methods are needed for earlier detection. METHODS PET imaging was used to assess metabolism‐perfusion in both sexes of aging C57BL/6J, and hAPOE mice, and were verified by transcriptomics, and immunopathology. RESULTS All hAPOE strains showed AD phenotype progression by 8 months, with females exhibiting the regional changes, which correlated with GO‐term enrichments for glucose metabolism, perfusion, and immunity. Uncoupling analysis revealed APOEε4/ε4 exhibited significant Type‐1 uncoupling (↓ glucose uptake, ↑ perfusion) at 8 and 12 months, while APOEε3/ε4 demonstrated Type‐2 uncoupling (↑ glucose uptake, ↓ perfusion), while immunopathology confirmed cell specific contributions. DISCUSSION This work highlights APOEε4 status in AD progression manifests as neurovascular uncoupling driven by immunological activation, and may serve as an early diagnostic biomarker. Highlights We developed a novel analytical method to analyze PET imaging of 18 F‐FDG and 64 Cu‐PTSM data in both sexes of aging C57BL/6J, and hAPOEε3/ε3, hAPOEε4/ε4, and hAPOEε3/ε4 mice to assess metabolism‐perfusion profiles termed neurovascular uncoupling. This analysis revealed APOEε4/ε4 exhibited significant Type‐1 uncoupling (decreased glucose uptake, increased perfusion) at 8 and 12 months, while APOEε3/ε4 demonstrated significant Type‐2 uncoupling (increased glucose uptake, decreased perfusion) by 8 months which aligns with immunopathology and transcriptomic signatures. This work highlights that there may be different mechanisms underlying age related changes in APOEε4/ε4 compared with APOEε3/ε4. We predict that these changes may be driven by immunological activation and response, and may serve as an early diagnostic biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Jackson Laboratory, Bar Harbor, Maine, USA.
- Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.
- The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
- Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Förderung
- NIA NIH HHS
- NIH/NIA
Zitieren
APA
Onos, K. D., Lin, P. B., Pandey, R. S., Persohn, S. A., Burton, C. P., Miner, E. W., Eldridge, K., Kanyinda, J. N., Foley, K. E., Carter, G. W., Howell, G. R., & Territo, P. R. (2024). Assessment of neurovascular uncoupling: APOE status is a key driver of early metabolic and vascular dysfunction. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13842
Vancouver
Onos KD, Lin PB, Pandey RS, Persohn SA, Burton CP, Miner EW, et al. Assessment of neurovascular uncoupling: APOE status is a key driver of early metabolic and vascular dysfunction. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13842
BibTeX
@article{Onos2024,
author = {Onos, Kristen D and Lin, Peter B and Pandey, Ravi S and Persohn, Scott A and Burton, Charles P and Miner, Ethan W and Eldridge, Kierra and Kanyinda, Jonathan Nyandu and Foley, Kate E and Carter, Gregory W and Howell, Gareth R and Territo, Paul R},
title = {Assessment of neurovascular uncoupling: APOE status is a key driver of early metabolic and vascular dysfunction},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.13842}
}
EUVIMED